The molnupiraviru distribution is the exception, not the rule

For the distribution of COVID-19 vaccines, a Vaccine Distribution System (SDS) has been established, which is run by the Government's Strategic Reserves Agency (RARS). In October 2021, the first two drugs for the treatment of COVID-19 were added to the SDS. In the following months, more drugs were added, including Lagevrio (molnupiravir). Vaccines and drugs are delivered by pharmaceutical wholesalers in accordance with the requirements of Good Distribution Practice (DPD).

Vaccines and drugs used in COVID-19 have obtained conditional approval and therefore cannot be included in the standard distribution chain. Therefore, it was necessary to create a unique way of distribution. The principle behind the SDS is the same from the outset: the vaccination center places an order for vaccines. The hospital or Primary Healthcare (POZ) facility places orders for drugs.

Organizations representing physicians from primary health care: the College of Family Physicians and the Healthcare Employers' Alliance sent letters to the Minister of Health regarding the distribution of Lagevrio (molnupiravir). The concern of doctors can be understood because, as a rule, they write out prescriptions that are dispensed in a pharmacy - this is the rule. Nevertheless, the concerns raised are unfounded as the molnupiravir distribution is an exception.

The president of the Lower Silesian Chamber of Pharmacists posted several entries on this subject on Twitter. One of them: "Another organization firmly about transferring the #molnupiravir distribution from POZ to pharmacies. The natural drug marketing channel optimizes the availability and security of medicinal products storage. Pharmacists can secure its logistics for the patient @RARS_GOV_PL @MZ_GOV_PL".
This is embarrassing gibberish, as it proves that the president does not know that the Pharmaceutical Law Act contains the following provisions:
Art. 65 sec. 1a. It does not constitute trade in medicinal products for the purposes of strategic reserves.
Art. 68 sec. 7. The minister competent for health matters specifies, by way of an ordinance: the list of medicinal products that may be provided ad hoc in connection with the provided health service, taking into account the type of service provided.

mgr. farm. Walenty Zajdel